Homoarginine, kidney function and cardiovascular mortality risk
Andreas Tomaschitz(Medical University of Graz), W. Marz(Medical University of Graz), Tanja B. Grammer(Synlab (Germany)), Stefan Pilz(Medical University of Graz), Elisabeth Kraigher‐Krainer(Charité - Universitätsmedizin Berlin), Christoph Wanner(Universitätsklinikum Würzburg), C. Drechsler(Université Claude Bernard Lyon 1), Bernd Genser(European Molecular Biology Organization), Andreas Meinitzer(Medical University of Graz), Astrid Fahrleitner‐Pammer(Medical University of Graz), Marcus E. Kleber(University of Mannheim), Jutta Rus-Machan, Vera Krane, Bernhard O. Boehm(University of Würzburg), E. Ritz(Heidelberg University), Burkert Pieske(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 34
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
|European Heart Journal|2019|1.8k
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k